Cognitive decline associated with pathological burden in primary age-related tauopathy
- PMID: 28322204
- PMCID: PMC5585025
- DOI: 10.1016/j.jalz.2017.01.028
Cognitive decline associated with pathological burden in primary age-related tauopathy
Abstract
Introduction: Primary age-related tauopathy (PART) is a neuropathological diagnosis characterized by tau neurofibrillary tangles (NFTs) in the absence of amyloid plaque pathology. Although most individuals over 50 years of age have evidence of NFTs, the clinical and cognitive consequences of PART are not known.
Methods: We evaluated 226 neuropathologically confirmed PART cases from the National Alzheimer's Coordinating Center database who participated in a total of 846 longitudinal neuropsychological assessments from the Alzheimer's Disease Center program's Uniform Data Set. Mixed-effects statistical models tested whether cognitive decline was associated with Braak stage NFT burden.
Results: Higher stages of NFT burden in PART, with no evidence or minimal evidence of amyloid pathology, were associated with more rapid decline on tasks involving episodic and semantic memory along with tests of processing speed and attention.
Discussion: We conclude that PART has cognitive consequences that should be considered in the context of emerging tau-targeted therapies in age-associated neurodegenerative diseases.
Keywords: Clinical prognosis; Cognition; Primary age-related tauopathy; Tau.
Copyright © 2017 the Alzheimer's Association. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Similar articles
-
Comparison of symptomatic and asymptomatic persons with primary age-related tauopathy.Neurology. 2017 Oct 17;89(16):1707-1715. doi: 10.1212/WNL.0000000000004521. Epub 2017 Sep 15. Neurology. 2017. PMID: 28916532 Free PMC article.
-
Cognitive trajectory in mild cognitive impairment due to primary age-related tauopathy.Brain. 2020 Feb 1;143(2):611-621. doi: 10.1093/brain/awz403. Brain. 2020. PMID: 31942622 Free PMC article.
-
Tau aggregation influences cognition and hippocampal atrophy in the absence of beta-amyloid: a clinico-imaging-pathological study of primary age-related tauopathy (PART).Acta Neuropathol. 2017 May;133(5):705-715. doi: 10.1007/s00401-017-1681-2. Epub 2017 Feb 3. Acta Neuropathol. 2017. PMID: 28160067 Free PMC article.
-
Roles of tau pathology in the locus coeruleus (LC) in age-associated pathophysiology and Alzheimer's disease pathogenesis: Potential strategies to protect the LC against aging.Brain Res. 2019 Jan 1;1702:17-28. doi: 10.1016/j.brainres.2017.12.027. Epub 2017 Dec 21. Brain Res. 2019. PMID: 29274876 Review.
-
Tauopathy: A common mechanism for neurodegeneration and brain aging.Mech Ageing Dev. 2019 Mar;178:72-79. doi: 10.1016/j.mad.2019.01.007. Epub 2019 Jan 19. Mech Ageing Dev. 2019. PMID: 30668956 Free PMC article. Review.
Cited by
-
Hippocampal Synaptic Alterations Associated with Tau Pathology in Primary Age-Related Tauopathy.medRxiv [Preprint]. 2023 Jun 7:2023.02.22.23286323. doi: 10.1101/2023.02.22.23286323. medRxiv. 2023. Update in: J Neuropathol Exp Neurol. 2023 Sep 20;82(10):836-844. doi: 10.1093/jnen/nlad064. PMID: 36865237 Free PMC article. Updated. Preprint.
-
Limbic Predominant Age-Related TDP-43 Encephalopathy (LATE): Clinical and Neuropathological Associations.J Neuropathol Exp Neurol. 2020 Mar 1;79(3):305-313. doi: 10.1093/jnen/nlz126. J Neuropathol Exp Neurol. 2020. PMID: 31845964 Free PMC article.
-
Differences in Cognitive Impairment in Primary Age-Related Tauopathy Versus Alzheimer Disease.J Neuropathol Exp Neurol. 2019 Mar 1;78(3):219-228. doi: 10.1093/jnen/nly132. J Neuropathol Exp Neurol. 2019. PMID: 30715383 Free PMC article.
-
Transcriptional signatures of hippocampal tau pathology in primary age-related tauopathy and Alzheimer's disease.Cell Rep. 2025 Mar 25;44(3):115422. doi: 10.1016/j.celrep.2025.115422. Epub 2025 Mar 13. Cell Rep. 2025. PMID: 40085647 Free PMC article.
-
Tau and MAPT genetics in tauopathies and synucleinopathies.Parkinsonism Relat Disord. 2021 Sep;90:142-154. doi: 10.1016/j.parkreldis.2021.09.008. Epub 2021 Sep 14. Parkinsonism Relat Disord. 2021. PMID: 34593302 Free PMC article. Review.
References
-
- McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Kawas CH, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7:263–9. doi: 10.1016/j.jalz.2011.03.005. - DOI - PMC - PubMed
-
- Yamada M. Senile dementia of the neurofibrillary tangle type (tangle-only dementia): neuropathological criteria and clinical guidelines for diagnosis. Neuropathology. 2003;23:311–7. - PubMed
-
- Knopman DS, Parisi JE, Salviati A, Floriach-Robert M, Boeve BF, Ivnik RJ, et al. Neuropathology of cognitively normal elderly. J Neuropathol Exp Neurol. 2003;62:1087–95. - PubMed
MeSH terms
Grants and funding
- P30 AG013854/AG/NIA NIH HHS/United States
- P50 AG005142/AG/NIA NIH HHS/United States
- P50 AG016573/AG/NIA NIH HHS/United States
- P50 AG047266/AG/NIA NIH HHS/United States
- P30 AG010161/AG/NIA NIH HHS/United States
- P50 AG025688/AG/NIA NIH HHS/United States
- P50 AG005133/AG/NIA NIH HHS/United States
- P50 AG005138/AG/NIA NIH HHS/United States
- P50 AG047366/AG/NIA NIH HHS/United States
- P30 AG019610/AG/NIA NIH HHS/United States
- P30 AG028383/AG/NIA NIH HHS/United States
- P50 AG033514/AG/NIA NIH HHS/United States
- P30 AG010124/AG/NIA NIH HHS/United States
- P50 AG023501/AG/NIA NIH HHS/United States
- P50 AG005131/AG/NIA NIH HHS/United States
- P30 AG010133/AG/NIA NIH HHS/United States
- P50 AG016574/AG/NIA NIH HHS/United States
- P50 AG005146/AG/NIA NIH HHS/United States
- P01 AG017586/AG/NIA NIH HHS/United States
- P30 AG035982/AG/NIA NIH HHS/United States
- P50 AG008702/AG/NIA NIH HHS/United States
- K08 AG039510/AG/NIA NIH HHS/United States
- U01 AG016976/AG/NIA NIH HHS/United States
- P30 AG008051/AG/NIA NIH HHS/United States
- P50 AG005681/AG/NIA NIH HHS/United States
- P30 AG013846/AG/NIA NIH HHS/United States
- P50 AG047270/AG/NIA NIH HHS/United States
- P50 AG005136/AG/NIA NIH HHS/United States
- P30 AG012300/AG/NIA NIH HHS/United States
- P50 AG016570/AG/NIA NIH HHS/United States
- P50 AG005134/AG/NIA NIH HHS/United States
- P30 AG008017/AG/NIA NIH HHS/United States
- K01 AG043503/AG/NIA NIH HHS/United States
- P30 AG010129/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical